Point72 Asia »

Allogene Therapeutics shares owned by Point72 Asia

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Point72 Asia from 13F filings

Historical chart of Point72 Asia investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Point72 Asia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Point72 Asia

Quarter filed Position value Share count Share price at filing
2023-12-31 $28k 8.8k 3.21

More positions owned by Point72 Asia

Chevron Corporation (CVX)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Williams Companies (WMB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Crescent Point Energy Trust (CPG)
Enerplus Corp (ERF)
Chord Energy Corporation Com New (CHRD)
Imperial Oil Com New (IMO)
Sunrun (RUN)
Jinkosolar Hldg Sponsored Adr (JKS)
Fortis (FTS)
ConocoPhillips (COP)
Pembina Pipeline Corp (PBA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Point72 Asia

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Charles Schwab Investment Management
Caxton Associates
Nordea Investment Management Ab

View all funds holding Allogene Therapeutics